The Egyptian International Pharmaceutical Industries Company (EIPICO) reported a strong financial performance in 2024, with consolidated net profits rising by 32.4% to reach EGP 1.09 billion, compared to EGP 823.3 million in 2023.

Total sales also grew significantly, increasing by 45.1% to EGP 7.59 billion in 2024, up from EGP 5.23 billion in the previous year.

Meanwhile, the company’s standalone financial statements showed a net profit of EGP 1.02 billion, compared to EGP 730.08 million during the same period in 2023.

Copied from Almal